Medical Director

This is an exciting opportunity working for our client to play a key role in bringing a life-changing treatment for Osteogenesis Imperfecta (OI) and other rare diseases to market in the UK. You will work within a dynamic and collaborative environment. If you are an MD with experience in and passion for medical affairs and rare diseases, we encourage you to apply.

Role Overview: IQVIA is seeking a highly skilled and motivated UK Medical Director to lead the pre-launch medical engagement activities for a groundbreaking treatment in Osteogenesis Imperfecta (OI) across the UK market. The successful candidate will play a pivotal role in developing and executing the UK medical affairs plan, collaborating closely with cross-functional teams and external stakeholders.

• Develop and implement the UK medical affairs plan with a primary focus on pre-launch activities for OI.
• Refine and execute the mapping of OI treatment centers, identifying key hubs and spokes, and collaborating with the Country Patient Access Lead to gather detailed insights into patient numbers, treatment pathways, and the overall OI landscape.
• Conduct field scientific interactions with healthcare professionals (HCPs) ensuring compliance with local regulations and guidelines.
• Support the SATURN Real World Evidence (RWE) Program in alignment with global medical strategies.
• Attend local OI scientific meetings, engage with Key Opinion Leaders (KOLs) and HCPs, and seek opportunities to present relevant scientific publications in line with the broader scientific communications strategy.
• Participate in Early Scientific Advice meetings, collaborating with local teams to prepare materials and present the medical strategy.
• Work closely with the Patient Access Lead to engage KOLs in dossier strategy development and support key stages of the reimbursement process, including hearing preparations.
• Contribute to specific Patient Access Strategy Plan, ensuring alignment between medical and patient access teams for the successful launch of the OI treatment.

• Qualified Doctor of Medicine (MD).
• Additional qualifications such as a university degree, Master’s, or Ph.D. in pharmaceutical science, healthcare management, or a related field are an advantage.
• 7-10 years of experience in medical affairs, preferably in a biotech or pharmaceutical company.
• Knowledge of the healthcare systems within the UK, with experience in the reimbursement pathway being an advantage.
• Proven track record of working in rare disease therapy development, with hands-on experience in medical affairs strategy and delivery during late-stage development and launch.

• Ability to work effectively within a cross-functional, matrix environment, contributing both to strategic planning and hands-on execution.
• Strong interpersonal and communication skills, with demonstrated experience working across international teams to deliver high-quality results.
• High emotional intelligence (EQ) with the ability to build trusted, long-term relationships within rare disease communities and across diverse stakeholders.
• Entrepreneurial mindset with the ability to innovate and shape new markets, particularly for therapies where no current alternatives exist.
• Self-motivated with a proactive, "can-do" attitude and a collaborative, low-ego team ethos.
• Strong organizational skills, with the ability to manage multiple projects while respecting timelines and deadlines.
• Excellent communication with experience presenting complex information to various audiences.
• Proficiency in Microsoft Office, especially Excel and PowerPoint, with strong presentation and analytical skills.
• Willingness to travel as needed and participate in face-to-face team meetings.

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.